scholarly article | Q13442814 |
P50 | author | Tomasz Mikula | Q59662161 |
Joanna Kozłowska | Q61086915 | ||
Alicja Wiercińska-Drapało | Q61086929 | ||
Magdalena Suchacz | Q86066223 | ||
Janusz Cianciara | Q117282454 | ||
P2093 | author name string | Joanna Jabnonska | |
Wojciech Stanczak | |||
P2860 | cites work | Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization | Q24301539 |
Management of hepatocellular carcinoma: An update | Q27860530 | ||
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis | Q28139159 | ||
Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor | Q28567494 | ||
Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration | Q28581050 | ||
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | Q30479629 | ||
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator | Q33708754 | ||
Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells | Q34162379 | ||
Moving toward an understanding of the metastatic process in hepatocellular carcinoma | Q34538224 | ||
Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence | Q34630306 | ||
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein | Q34726812 | ||
Regulating the angiogenic balance in tissues | Q35062979 | ||
Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase | Q35796951 | ||
PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. | Q36589655 | ||
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients. | Q36611209 | ||
Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy. | Q37603976 | ||
The role of PEDF in tumor growth and metastasis | Q37710604 | ||
Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders | Q37737754 | ||
The role of serum response factor in hepatocellular carcinoma: an association with matrix metalloproteinase | Q38471378 | ||
Pigment epithelial-derived factor inhibits c-FLIP expression and assists ciglitazone-induced apoptosis in hepatocellular carcinoma | Q39555459 | ||
Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). | Q40025887 | ||
Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients | Q42978008 | ||
Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients | Q43035878 | ||
Screening for liver cancer: results of a randomised controlled trial in Qidong, China | Q45107131 | ||
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients | Q46725095 | ||
Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin | Q48058006 | ||
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer | Q70521319 | ||
Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential | Q71216097 | ||
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma | Q71748715 | ||
Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers | Q73939859 | ||
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution | Q80087614 | ||
Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis | Q82358138 | ||
Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population | Q82578684 | ||
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome | Q82755602 | ||
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features | Q83094497 | ||
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients | Q83910377 | ||
Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma | Q84117734 | ||
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation | Q84152980 | ||
Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis | Q84882625 | ||
Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells | Q85181125 | ||
P433 | issue | 5 | |
P921 | main subject | liver cirrhosis | Q147778 |
P304 | page(s) | 375-379 | |
P577 | publication date | 2016-09-01 | |
P1433 | published in | Saudi Journal of Gastroenterology | Q15817344 |
P1476 | title | Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis | |
P478 | volume | 22 |
Q41169776 | Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas |
Q91742213 | Prognostic roles of miR-124-3p and its target ANXA7 and their effects on cell migration and invasion in hepatocellular carcinoma |
Q90467683 | The contrary intracellular and extracellular functions of PEDF in HCC development |
Search more.